Advertisement

Journal of Endocrinological Investigation

, Volume 32, Issue 1, pp 13–17 | Cite as

Calpain 10 gene single-nucleotide 44 polymorphism may have an influence on clinical and metabolic features in patients with polycystic ovary syndrome

  • M. Yılmaz
  • E. Yurtçu
  • H. Demirci
  • M. A. Ergün
  • R. Ersoy
  • A. Karakoç
  • I. Yetkin
  • N. Çakır
  • G. Ayvaz
  • M. Arslan
Original Articles

Abstract

Aim: This study was designed in order to examine the relationship between Calpain 10 [single-nucleotide polymorphism (SNP) 19,43,44,63] gene polymorphisms and clinical and hormonal characteristics in women with polycystic ovary syndrome (PCOS). Materials and methods: One hundred and seven patients with PCOS and 114 healthy subjects were included in this study. Serum levels of sex steroids were measured for each individual. Insulin resistance (IR) was evaluated by the homeostasis model assessment (HOMA) and quantitative insulin-sensitivity check index (QUICKI) methods. Insulin and glucose responses to the oral glucose tolerance test (OGTT) were analyzed by calculating the areas under the curve for insulin (AUCI) and glucose by the trapezoidal methods. We used PCR and restriction fragment length polymorphism technique to examine Calpain 10 SNP 19, 43, 44, and 63 polymorphisms. Results: Allele distribution of Calpain 10 SNP 44 gene polymorphism was observed as significantly different between the groups. Calpain 10 SNP 44 TC genotype was found to be increased in PCOS subjects (69.15%) compared to the control subjects (50%). However, when compared to control subjects, patients with PCOS had similar Calpain 10 SNP 19, Calpain 10 SNP 43, and SNP 63 gene polymorphisms. When compared with normal Calpain 10 gene SNP 44 allele in PCOS subjects, subjects with PCOS having Calpain 10 gene SNP 44 allele polymorphism had higher free testosterone, androstenedione, DHEA-S, and fasting insulin levels. Also, PCOS women with Calpain 10 gene SNP 44 allele polymorphism had high Ferriman-Gallwey (F-G) score, acne, prevalence of menstrual disturbances, waist-hip ratio, HOMA-IR, AUCI levels and low QUICKI levels. Conclusion: The findings show that Calpain 10 gene SNP 44 allele polymorphism may have a role in PCOS pathogenesis. However, larger-scale studies are needed in this field.

Key-words

Androgen Calpain 10 gene hirsutismus insulin resistance PCOS PCR RFLP 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Homburg R. What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome. Human Reprod 2002, 17: 2495–9.CrossRefGoogle Scholar
  2. 2.
    Dunaif A, Segal K, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989, 38: 1165–74.PubMedCrossRefGoogle Scholar
  3. 3.
    Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalance of impaired glucose tolerance and diabetes in women polycystic ovary syndrome. Diabetes Care 1999, 22: 141–6.PubMedCrossRefGoogle Scholar
  4. 4.
    Wild S, Pierpoint T, McKeigue P, Jacobs H. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol (Oxf) 2000, 52: 595–600.CrossRefGoogle Scholar
  5. 5.
    Horikawa Y, Oda N, Cox NJ, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000, 26: 163–75.PubMedCrossRefGoogle Scholar
  6. 6.
    Evans JC, Frayling TM, Cassell PG, et al. Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet 2001, 69: 544–52.PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Garant MJ, Kao WH, Brancati F, et al. SNP43 of CAPN10 and the risk of type 2 diabetes in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes 2002, 51: 231–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Weedon MN, Schwarz PE, Horikawa Y, et al. Meta-analysis and a large association study confirm a role for calpain 10 variation in type 2 diabetes susceptibility. Am J Hum Genet 2003, 73: 1208–12.PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Gonzalez A, Abril E, Roca A, et al. Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary syndrome. J Clinical Endocrinol Metab 2003, 88: 5529–36.CrossRefGoogle Scholar
  10. 10.
    Gonzalez A, Abril E, Roca A, et al. CAPN10 alleles are associated with polycystic ovary syndrome. J Clin Endocrinol Metab 2002, 87: 3971–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Haddad L, Evans JC, Gharani N, et al. Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome. J Clin Endocrinol Metab 2002, 87: 2606–10.PubMedCrossRefGoogle Scholar
  12. 12.
    Ehrmann DA, Schwarz PEH, Hara M, et al. Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome. J Clin Endocrinol Metab 2002, 87: 1669–73.PubMedCrossRefGoogle Scholar
  13. 13.
    The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004, 19: 41–7.CrossRefGoogle Scholar
  14. 14.
    Ferriman D, Gallwey JD. Clinical assesment of body hair growth in women. J Clin Endocrinol Metab 1961, 21: 1440–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Genuth S, Alberti KG, Bennett P, et al; Expert Committee on the Diagnosis and Classification. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26: 3160–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Matthews DR, Hosker JP and Rudenski AS. Homeostasis model assesssment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28: 412–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85: 2402–10.PubMedCrossRefGoogle Scholar
  18. 18.
    Shima Y, Nakanishi K, Odawara M, Kobayashi T, Ohta H. Association of the SNP-19 genotype 22 in the calpain-10 gene with elevated body mass index and hemoglobin A1c levels in Japanese. Clin Chim Acta 2003, 336: 89–96.PubMedCrossRefGoogle Scholar
  19. 19.
    Daimon M, Oizumi T, Saitoh T, et al. Calpain 10 gene polymorphisms are related, not to type 2 diabetes, but to increased serum cholesterol in Japanese. Diabetes Res Clin Pract 2002, 56: 147–52.PubMedCrossRefGoogle Scholar
  20. 20.
    Orho-Melander M, Klannemark M, Svensson MK, Ridderstråle M, Lindgren CM, Groop L. Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels. Diabetes 2002, 51: 2658–64.PubMedCrossRefGoogle Scholar
  21. 21.
    Malecki MT, Moczulski DK, Klupa T, et al. Homozygous combination of calpain 10 gene haplotypes is associated with type 2 diabetes mellitus in a Polish population. Eur J Endocrinol 2002, 146: 695–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Vollmert C, Hahn S, Lamina C, et al; the KORA group. Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians. Am J Physiol Endocrinol Metab 2007, 292: E836–44.PubMedCrossRefGoogle Scholar
  23. 23.
    Wiltgen D, Furtado L, Kohek MB, Spritzer PM. CAPN10 UCSNP-43, UCSNP-19and UCSNP-63 polymorphisms and metabolic syndrome in polycystic ovary syndrome. Gynecol Endocrinol 2007, 23: 173–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Escobar-Morreale HF, Peral B, Villuendas G, Calvo RM, Sancho J, San Millán. Common single nucleotide polymorphisms in intron 3 of the calpain-10 gene influence hirsutism. Fertil Steril 2002, 77: 581–7.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2009

Authors and Affiliations

  • M. Yılmaz
    • 1
  • E. Yurtçu
    • 2
  • H. Demirci
    • 3
  • M. A. Ergün
    • 4
  • R. Ersoy
    • 3
  • A. Karakoç
    • 3
  • I. Yetkin
    • 3
  • N. Çakır
    • 3
  • G. Ayvaz
    • 3
  • M. Arslan
    • 3
  1. 1.Department of Endocrinology and Metabolism, Faculty of MedicineKırıkkale University Sağ_lik CaddesiKırıkkaleTurkey
  2. 2.Department of Medical Biology and Genetics, Faculty of MedicineBaskent UniversityTurkey
  3. 3.Department of Endocrinology and MetabolismGazi UniversityAnkaraTurkey
  4. 4.Department of Medical Genetics, Faculty of MedicineGazi UniversityAnkaraTurkey

Personalised recommendations